Navigation Links
Phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer 'promising'
Date:1/15/2014

An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer. The group reports that the addition of Bevacizumab to the existing standard of care was safe and showed promising overall results. The 2- and 3- year overall survival rates were 89.8 percent and 80.2 percent, respectively.

"Cervical cancer is a huge problem worldwide, but isn't as big a problem in the United States. So in many ways it tends to become a somewhat overlooked and under-studied disease," says Tracey Schefter, MD, investigator at the University of Colorado Cancer Center, director of the Stereotactic Body Radiation Therapy program at the University of Colorado School of Medicine, and the study's lead author.

Risk factors for cervical cancer include infection with the human papilloma virus (HPV). Screening dramatically reduces both the likelihood of developing cervical cancer and the disease's mortality rate. Combined, these two factors mean that 80 percent of the world's approximately 473,000 yearly cases of cervical cancer occur in the developing world. In the United States, cervical cancer rates have dropped 74 percent over the previous 50 years, but is still diagnosed in approximately 10,000 women per year, with 3,500 deaths due to the disease.

The current phase II clinical trial enrolled 49 eligible patients from 28 institutions in the years 2006-2009. The study previously reported that Bevacizumab was safe and well-tolerated in combination with cisplatin and radiation therapy in this population. Now the group reports on the secondary efficacy endpoints at a median follow-up time of 3.8 years.

Specifically the group evaluated the addition of 10mg/kg bevacizumab every two weeks for 3 cycles during
'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. ALS patients differ on treatment choices in later phases of disease
2. Reach2HD, a Phase II study in Huntingtons disease, launched
3. Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
4. Phase III trial of dapivirine ring begins in Africa: New HIV prevention approach for women
5. IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
6. COPD Foundation and BWH announces second phase of groundbreaking COPDGene project
7. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
8. Positive results from Phase 1/2 stem cell trial reported
9. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
10. Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Phase II trial of Bevacizumab (Avastin) in locally advanced cervical cancer 'promising'
(Date:7/23/2014)... or itchy skin lesions could be a warning sign ... multiple lesions that are suspicious looking, and those that ... non-melanoma skin cancers," study author Dr. Gil Yosipovitch, chairman ... in a Temple University Health System news release. ... who were confirmed to have skin cancer lesions between ...
(Date:7/23/2014)... Agricultural and Forestry University in Shaanxi province, and the ... agreement that lays the groundwork for establishing the Sino-U.S. ... The signing ceremony was held in the city of ... the U.S. Department of Agriculture and China,s Ministry of ... event for UC Davis and for our World Food ...
(Date:7/23/2014)... 2014 The American Telemedicine Association ... twentieth annual meeting and tradeshow focused exclusively on ... attract over 5,000 attendees and more than 250 ... 3-5, 2015, in Los Angeles. , ATA’s annual ... professionals from researchers, clinicians, hospital and university administrators, ...
(Date:7/23/2014)... Bodybuilding.com, the Internet’s most-visited bodybuilding and ... supplements, has officially opened the polls for their tenth ... fastest growing sports nutrition company, is up for eight ... Year, Best Tasting Protein of the Year- Whey-HD™, Most ... year - Whey-HD™, Pre-workout Supplement of the Year - ...
(Date:7/23/2014)... The voice on the recording was low and calm as the ... infected with the human immunodeficiency virus (HIV) that causes AIDS: “My ... know I was on the floor flat on my face boohooing, ... the recording ended less than 10 minutes later. “Don’t feel like ... it is just God setting you up for something greater,” the ...
Breaking Medicine News(10 mins):Health News:Painful, Itchy Patches Could Be Sign of Skin Cancer 2Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3
... opportunity destroyer. It attacks the central nervous system and ... are celebrated cellist Jacqueline du Pre, whose career was ended ... but they are far from alone. ... 400,000 cases in the U.S. and more that 2 million ...
... (Apr. 29, 2010) -- Mice, frogs, and E. ... the last few years, due in part to technical advances, ... evolution and development, the range of organisms used for research ... choosing a model system that might better address their specific ...
... universal health care, economic equality as reasons why , ... healthier lives than Americans, likely due to the United ... of social and economic equality, a new study suggests. ... States Survey of Health 2002-03 and found that Canadians ...
... ... is set for official release October 5, 2010 with pre-orders available now through Barnes and ... ... his work with the legendary jazz group ‘Pieces of a Dream," and the infamous Los ...
... ... families that love them , ... (PRWEB) April 29, 2010 -- Still hunting for the perfect Mother,s Day gift idea? While ... thing that mothers universally don,t have enough of is sleep. With Mother,s Day right around the ...
... ... Invisalign clear aligners, a new technology that may eventually make unattractive, uncomfortable braces completely ... before. , ... California (PRWEB) April 29, 2010 -- Torrance orthodontist Dr. Robert Mondavi is ...
Cached Medicine News:Health News:Catching multiple sclerosis before it strikes 2Health News:Catching multiple sclerosis before it strikes 3Health News:Canadians Leading Longer, Healthier Lives Than Americans 2Health News:R&B Recording Artist / King of Hancock Park Norwood Young Set to Launch Reality Documentary and Autobiography 2Health News:R&B Recording Artist / King of Hancock Park Norwood Young Set to Launch Reality Documentary and Autobiography 3Health News:The Perfect Mother's Day Gift Idea: A Good Night's Sleep 2Health News:Invisalign Clear Aligners Available at Blue Sky Family Dental by Torrance Dentist, Dr. Robert Mondavi 2Health News:Invisalign Clear Aligners Available at Blue Sky Family Dental by Torrance Dentist, Dr. Robert Mondavi 3
(Date:7/23/2014)... -- The Board of Directors of VirtualScopics, Inc. (NASDAQ: ... trial imaging solutions, announced today that Eric T. ... executive officer, effective immediately.  Mr. Converse joined the company,s ... the positions of interim president and chief executive officer ... E. Phelps , Ph.D., chairman of the company,s Board ...
(Date:7/23/2014)... Wis. and MOUNTAIN VIEW, Calif. ... ("Surpass"), a recognized leader in translational preclinical research, today ... www.surpassinc.com ), signaling the transformation of Surpass, corporate ... innovation partner for our customers. This press release comes ... two integral hires were added to the Silicon Valley ...
(Date:7/23/2014)... 23, 2014 Pharmavite LLC announced that Timothy ... officer effective immediately. Toll recently served as Pharmavite,s executive ... category management, private label and sales administration in ... global role, Toll will expand his responsibilities to include ... "Toll,s appointment to chief customer officer is part ...
Breaking Medicine Technology:Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 2Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 4SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 2SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 3
... to Millennium Research Group (MRG), the global authority on medical ... to be used in a narrow set of indications over ... at a much lower rate than previously expected.  With a ... to the nonfusion market as a whole which is growing ...
... CAMBRIDGE, Mass., Sept. 1 Pfizer Inc. ... Pharmaceuticals, Inc., a privately held drug discovery ... they have entered into an agreement under ... (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO) ...
Cached Medicine Technology:European Interspinous Process Decompression Device Market Will Grow Nominally at 1.2% over the Next Five Years 2European Interspinous Process Decompression Device Market Will Grow Nominally at 1.2% over the Next Five Years 3Pfizer to Acquire FoldRx Pharmaceuticals 2Pfizer to Acquire FoldRx Pharmaceuticals 3Pfizer to Acquire FoldRx Pharmaceuticals 4Pfizer to Acquire FoldRx Pharmaceuticals 5Pfizer to Acquire FoldRx Pharmaceuticals 6
Button shape tip, round serrated handle, dull finish, overall length 130 mm....
... is the first and only one-bottle lens ... and conditions gas permeable contact lenses, but ... to the leading two-bottle GP lens care ... upon insertion by enveloping the lenses and ...
Overall length 355 mm, 14.0 inches....
Achievement, available exclusively from Art Optical, is a unique RGP lens design with a patented junctionless back surface and a controlled edge lift....
Medicine Products: